3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline
Product Type
Impurity Standards
CAT. No.
MRL-R18030
CAS. No.
106274-78-6
Mol. F.
C12H20N2
Mol. Wt.
192.31
Synonyms
NA
Chemical Name
3-(2-(Dimethylamino)ethyl)-N,N-dimethylaniline
Stock Status
3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline with CAS No: 106274-78-6 is an impurity standard of Rivastigmine. Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration. Buy high quality 3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of 3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline